【レポートの概要（一部）】
1. Report Overview
1.1 Global
1.1 Global Allergic Rhinitis Drugs: Market Overview
1.2 Global Allergic Rhinitis Drugs Market Segmentation
1.3 Why You Should Read This Report
1.4 How This Report Delivers
1.5 Key Questions Answered By This Analytical Report
1.6 Who Is This Report For?
1.7 Methodology
1.8 Frequently Asked Questions (FAQ)
1.9 Associated Reports
1.10 About Visiongain
2. An Introduction To Allergic Rhinitis Drugs
2.1 The Pharmaceutical Industry: A Brief Introduction
2.1.1 Allergic Rhinitis Treatments – An Industry Overview
2.2 A Brief Overview Of Allergy
2.3 Allergic Rhinitis
2.3.1 The Global Prevalence Of Allergic Rhinitis
2.3.2 Pathophysiology Of Allergic Rhinitis: IgEs And Mast Cells
2.3.3 Symptoms Of Allergic Rhinitis
2.3.4 Classification Of Allergic Rhinitis
2.3.4.1 Non-Allergic Rhinitis And Mixed Rhinitis
2.3.5 Seasonal Allergic Rhinitis (Hay Fever)
2.3.6 Perennial Allergic Rhinitis
2.3.7 Diagnosis Of Allergic Rhinitis
2.4 Treatment Of Allergic Rhinitis
2.4.1 Antihistamines
2.4.1.1 First-Generation Antihistamines
2.4.1.2 Second- And Third-Generation Antihistamines
2.4.2 Corticosteroids
2.4.2.1 First-, Second- And Third-Generation Intranasal Corticosteroids
2.4.2.2 Combination Drug Products
2.4.3 Leukotriene Receptor Antagonists
2.4.4 Cromolyn (cromoglicic acid)
2.4.5 Decongestants
2.4.6 Saline Nasal Sprays
2.4.7 Immunotherapy And Vaccines
2.5 Phases Of Clinical Trials
2.6 Scope Of This Report
3. The Global Allergic Rhinitis Drugs Market, 2015-2025
3.1 The Global Allergic Rhinitis Drugs Market: Market Overview
3.2 Categorisation Of The Global Allergic Rhinitis Drugs Market
3.3 The Global Allergic Rhinitis Drugs Market In 2014
3.4 Leading Allergic Rhinitis Drugs, 2015
3.5 The Global Allergic Rhinitis Drugs Market: Market Forecast 2015-2025
3.6 Allergic Rhinitis Drugs: Changing Market Shares By Sector 2015-2025
4. The Intranasal Antihistamines Market: Market Analysis And Forecast 2015-2025
4.1 Leading Products In The Intranasal Antihistamines Market, 2014
4.2 Intranasal Antihistamines: Market Trends And Developments, 2015
4.2.1 Azelastine Versus Olopatadine
4.2.2 Intranasal Combination Products
4.3 Intranasal Antihistamines: Market Forecast 2015-2025
4.3.1 Intranasal Antihistamines: Market Forecast by Volume, 2015-2025
4.3.2 Intranasal Antihistamines: Changing Market Shares By Leading Drugs 2015-2025
4.4 Leading Intranasal Antihistamines
4.5 Patanase (olopatadine) – Novartis
4.5.1 Patanase: Sales Forecast 2015-2025
4.6 Astepro (azelastine) – Meda Pharmaceuticals
4.6.1 Astepro: Sales Forecast 2015-2025
4.7 Astelin (azelastine) – Meda Pharmaceuticals
4.7.1 Astelin: Sales Forecast 2015-2025
4.8 Dymista (azelastine/fluticasone) – Meda Pharmaceuticals
4.8.1 Dymista: Sales Forecast 2015-2025
4.9 Generic Intranasal Azelastine
4.9.1 Generic Intranasal Azelastine: Sales Forecast By Value, 2015-2025
4.9.2 Generic Intranasal Azelastine: Sales Forecast By Volume, 2015-2025
4.10 Generic Intranasal Olopatadine
4.10.1 Generic Intranasal Olopatadine: Sales Forecast By Value, 2015-2025
4.10.2 Generic Intranasal Olopatadine: Sales Forecast By Volume, 2015-2025
5. Intranasal Corticosteroids Market: Market Analysis And Forecast 2015-2025
5.1 Leading Products In The Intranasal Corticosteroids Market, 2014
5.2 Intranasal Corticosteroids: Market Forecast 2015-2025
5.2.1 Intranasal Corticosteroids: Market Forecast by Volume, 2015-2025
5.2.2 Intranasal Corticosteroids: Changing Market Shares By Leading Drugs 2015-2025
5.3 Leading Intranasal Corticosteroids
5.4 Nasonex (mometasone) – Merck
5.4.1 Nasonex: Sales Forecast by Value, 2015-2025
5.4.2 Nasonex: Sales Forecast by Volume, 2015-2025
5.5 Avamys/Veramyst (fluticasone furoate) – GlaxoSmithKline
5.5.1 Avamys/Veramyst: Sales Forecast by Value, 2015-2025
5.5.2 Avamys/Veramyst: Sales Forecast by Volume, 2015-2025
5.6 Flixonase/Flonase/Flonase-OTC (fluticasone propionate) – GlaxoSmithKline
5.6.1 Flixonase/Flonase/Flonase-OTC: Sales Forecast By Value, 2015-2025
5.6.2 Flixonase/Flonase/Flonase-OTC: Sales Forecast By Volume, 2015-2025
5.7 Rhinocort (budesonide) – AstraZeneca
5.7.1 Rhinocort: Sales Forecast by Value, 2015-2025
5.7.2 Rhinocort: Sales Forecast by Volume, 2015-2025
5.8 Omnaris (ciclesonide) – Dainippon Sumitomo/Takeda
5.8.1 Omnaris: Sales Forecast By Value, 2015-2025
5.8.2 Omnaris: Sales Forecast By Volume, 2015-2025
5.9 Nasacort/Nasacort-OTC (triamcinolone) – Sanofi
5.9.1 Nasacort/Nasacort-OTC: Sales Forecast By Value, 2015-2025
5.9.2 Nasacort: Sales Forecast By Volume, 2015-2025
5.10 Beconase/Beconase AQ (beclometasone) – GlaxoSmithKline/Omega Pharma
5.10.1 Beconase/Beconase AQ: Sales Forecast By Value, 2015-2025
5.10.2 Beconase/Beconase AQ: Sales Forecast by Volume, 2015-2025
5.11 Qnasl (beclometasone) – Teva
5.11.1 Qnasl: Sales Forecast by Value, 2015-2025
5.11.2 Qnasl: Sales Forecast by Volume, 2015-2025
5.12 Zetonna (ciclesonide) – Dainippon Sumitomo
5.12.1 Zetonna: Sales Forecast By Value, 2015-2025
5.12.2 Zetonna: Sales Forecast By Volume, 2015-2025
5.13 Generic Intranasal Corticosteroids
5.13.1 Generic Intranasal Beclometasone
5.13.1.1 Generic Intranasal Beclometasone: Sales Forecast By Value, 2015-2025
5.13.1.2 Generic Intranasal Beclometasone: Sales Forecast By Volume, 2015-2025
5.13.2 Generic Intranasal Budesonide
5.13.2.1 Generic Intranasal Budesonide: Sales Forecast By Value, 2015-2025
5.13.2.2 Generic Intranasal Budesonide: Sales Forecast By Volume, 2015-2025
5.13.3 Generic Intranasal Flunisolide
5.13.3.1 Generic Intranasal Flunisolide: Sales Forecast By Value, 2015-2025
5.13.3.2 Generic Intranasal Flunisolide: Sales Forecast By Volume, 2015-2025
5.13.4 Generic Intranasal Fluticasone
5.13.4.1 Generic Intranasal Fluticasone: Sales Forecast By Value, 2015-2025
5.13.4.2 Generic Intranasal Fluticasone: Sales Forecast By Volume, 2015-2025
5.13.5 Generic Intranasal Mometasone
5.13.5.1 Generic Intranasal Mometasone: Sales Forecast By Value, 2015-2025
5.13.5.2 Generic Intranasal Mometasone: Sales Forecast By Volume, 2015-2025
5.13.6 Generic Intranasal Triamcinolone
5.13.6.1 Generic Intranasal Triamcinolone: Sales Forecast By Value, 2015-2025
5.13.6.2 Generic Intranasal Triamcinolone: Sales Forecast By Volume, 2015-2025
6. Oral Antihistamines Market: Market Analysis And Forecast 2015-2025
6.1 Oral Antihistamines: Market Overview
6.1.1 Leading Products In The Oral Antihistamines Market, 2014
6.2 Oral Antihistamines: Market Trends And Developments, 2015
6.2.1 Patent Expiries And The Threat Of Generics
6.2.2 The Increasing Switch From Prescription To Over-The-Counter Sales
6.2.3 The Potential For Combination Therapy With Intranasal Corticosteroids
6.3 Oral Antihistamines: Market Forecast 2015-2025
6.3.1 Oral Antihistamines: Changing Market Shares By Leading Drugs 2015-2025
6.4 Leading Oral Antihistamines For The Treatment Of Allergic Rhinitis
6.5 Allegra/Allegra-D/Allegra OTC (fexofenadine) – Sanofi
6.5.1 Allegra/Allegra OTC: Historical Sales, 1995-2014
6.5.2 Allegra/Allegra OTC: Sales Forecast 2015-2025
6.6 Zyrtec/Zyrtec D (cetirizine) – Johnson & Johnson/ UCB/ GSK
6.6.1 Zyrtec/Zyrtec D: Sales Forecast 2015-2025
6.7 Claritin/Claritin OTC (loratadine) – Bayer/ Merck & Co
6.7.1 Claritin/Claritin OTC: Sales Forecast 2015-2025
6.8 Xyzal (levocetirizine) – Sanofi/ UCB/ GSK
6.8.1 Xyzal: Sales Forecast 2015-2025
6.9 Allelock (olopatadine) – Kyowa Hakko Kirin
6.9.1 Allelock: Sales Forecast 2015-2025
6.10 Clarinex (desloratadine) – Merck & Co.
6.10.1 Clarinex: Sales Forecast 2015-2025
6.11 Ebastel (ebastine) – AstraZeneca/Takeda/Dainippon Sumitomo
6.11.1 Ebastel: Sales Forecast 2015-2025
6.12 Talion (bepotastine) – Mitsubishi Tanabe
6.12.1 Talion: Sales Forecast 2015-2025
6.13 Other Oral Antihistamines: Sales Forecast 2015-2025
7. Immunotherapy And Vaccines: Market Analysis And Forecast 2015-2025
7.1 Immunotherapy And Vaccines: Market Overview
7.1.1 Immunotherapy: Primed For Rapid Expansion
7.2 Leading Immunotherapy Products In The Allergic Rhinitis Market, 2014
7.3 Allergic Rhinitis Immunotherapy: Market Trends And Developments, 2015
7.3.1 Subcutaneous And Sublingual Immunotherapy
7.3.2 Expansion Into The US Market
7.3.3 Standardisation Of Immunotherapy Products
7.3.4 Immunotherapy As A Preventative Treatment
7.4 Allergic Rhinitis Immunotherapy: Market Forecast 2015-2025
7.4.1 Allergic Rhinitis Immunotherapy: Changing Market Shares By Leading Products 2015-2025
7.5 Immunotherapy Type – By Route Of Administration, 2014
7.6 Leading Immunotherapy Products For Allergic Rhinitis
7.7 Staloral (Grass pollen allergen extract) – Stallergenes
7.7.1 Staloral: Sales Forecast 2015-2025
7.8 Alutard SQ (Grass pollen allergen extract) – ALK-Abelló
7.8.1 Alutard SQ: Sales Forecast 2015-2025
7.9 Grazax/Grastek (Timothy grass pollen allergen extract) – ALK-Abelló/Merck
7.9.1 Grazax/Grastek: Sales Forecast 2015-2025
7.10 Oralair (Grass pollen allergen extract) – Stallergenes/Greer
7.10.1 Oralair: Sales Forecast 2015-2025
7.11 Ragwitek (Short ragweed pollen allergen extract) – Merck
7.11.1 Ragwitek: Sales Forecast 2015-2025
7.12 Other Allergic Rhinitis Immunotherapy Products: Sales Forecast 2015-2025
8. Leading National Markets For Allergic Rhinitis Drugs, 2015-2025
8.1 The Allergic Rhinitis Drugs Market By Region
8.1.1 The Global Distribution Of Allergic Rhinitis Drugs In 2014
8.2 Leading National Markets: Forecast 2015-2025
8.2.1 Changing Market Shares By Region, 2015-2025
8.3 Regional Allergic Rhinitis Drugs Markets: Analysis And Forecasts, 2015-2025
8.4 United States: The Largest Allergic Rhinitis Drugs Market
8.4.1 US Allergic Rhinitis Drugs Market: Trends And Developments
8.4.1.1 The Trend Of Rx-to-OTC Switching
8.4.2 US Allergic Rhinitis Drugs Market: Market Forecast 2015-2025
8.5 EU5
8.5.1 EU5 Allergic Rhinitis Drugs Market: Market Forecast 2015-2025
8.5.1.1 EU5 Markets: Changing Market Shares By Country, 2015-2025
8.5.2 Germany
8.5.2.1 Germany: Reform Of AMNOG Pharmaceutical Rebate Law
8.5.2.2 German Allergic Rhinitis Drugs Market: Market Forecast 2015-2025
8.5.3 UK
8.5.3.1 UK: Increasing Burden Of Allergy
8.5.3.2 UK Allergic Rhinitis Drugs Market: Market Forecast 2015-2025
8.5.4 France
8.5.4.1 France: Social Security Finance Act 2015
8.5.4.2 French Allergic Rhinitis Drugs Market: Market Forecast 2015-2025
8.5.5 Italy
8.5.5.1 Italy: Government Cost Cutting Measures Impacting Market Growth
8.5.5.2 Italian Allergic Rhinitis Drugs Market: Market Forecast 2015-2025
8.5.6 Spain
8.5.6.1 Spanish Allergic Rhinitis Drugs Market: Market Forecast 2015-2025
8.6 China
8.6.1 Air Pollution Associated With Increasing Prevalence
8.6.2 Expansion Of Healthcare Coverage And Reimbursement In China
8.6.3 Chinese Allergic Rhinitis Drugs Market: Market Forecast 2015-2025
8.7 Japan
8.7.1 Cedar Reforestation And The Hay Fever Epidemic
8.7.2 Genetically Modified Rice As Immunotherapy
8.7.3 Effects Of The Rising Levels Of Generic Drug Penetration
8.7.4 Japanese Allergic Rhinitis Drugs Market: Market Forecast 2015-2025
8.8 Russia
8.8.1 How Will Russia’s Economic Status Affect Its Pharma Industry?
8.8.2 Russian Allergic Rhinitis Drugs Market: Market Forecast 2015-2025
8.9 India
8.9.1 The Impact Of The Drug Prices Control Order On Indian Pharma
8.9.2 India’s Expansion Of Healthcare Provision
8.9.3 Indian Allergic Rhinitis Drugs Market: Market Forecast 2015-2025
8.10 Brazil
8.10.1 How Will Brazil’s Growing Healthcare Influence Allergic Rhinitis Drugs
8.10.2 Brazilian Allergic Rhinitis Drugs Market: Market Forecast 2015-2025
8.11 Mexico
8.11.1 Are Multinationals Waking Up To Mexico’s Market Potential?
8.11.2 Mexican Allergic Rhinitis Drugs Market: Market Forecast 2015-2025
8.12 Rest of the World
8.12.1 Rest of the World Allergic Rhinitis Drugs Market: Market Forecast 2015-2025
9. Leading Companies In The Allergic Rhinitis Drugs Market, 2015-2025
9.1 Allergic Rhinitis Drugs – An Evolving Market Space
9.1.1 Leading Companies In The Allergic Rhinitis Drugs Market, 2015
9.1.2 Allergic Rhinitis Drugs Market: Leading Companies Forecast 2015-2025
9.1.3 Allergic Rhinitis Drugs: Changing Market Shares By Leading Companies 2015-2025
9.2 ALK-Abelló
9.2.1 ALK-Abelló: Allergic Rhinitis Drugs Portfolio, 2015
9.2.2 ALK-Abelló: Recent Developments
9.2.2.1 Progress In The Approval Process For House Dust Mite (HDM) SLIT-Tablet
9.2.2.2 ALK Collaborates With EddingPharm To Boost China Sales
9.2.2.3 Jext Product Recall And The Subsequent Recovery
9.2.3 ALK-Abelló: Sales Forecast 2015-2025
9.2.4 ALK-Abelló: Allergic Rhinitis Drug Development Pipeline, 2015
9.3 GlaxoSmithKline (GSK)
9.3.1 GlaxoSmithKline: Allergic Rhinitis Drugs Portfolio, 2015
9.3.2 GlaxoSmithKline: Recent Developments
9.3.2.1 GSK Asset Swap with Novartis To Restructure Consumer Health
9.3.2.2 GSK Divestment of OTC Products
9.3.3 GlaxoSmithKline: Sales Forecast 2015-2025
9.3.4 GlaxoSmithKline: Allergic Rhinitis Drug Development Pipeline, 2015
9.4 Johnson & Johnson
9.4.1 Johnson & Johnson: Allergic Rhinitis Drugs Portfolio, 2015
9.4.2 Johnson & Johnson: Recent Developments
9.4.2.1 Launch of Zyrtec Dissolve Tabs
9.4.2.2 Manufacturing Recalls At McNeil Consumer Healthcare
9.4.3 Johnson & Johnson: Sales Forecast 2015-2025
9.5 Kyowa Hakko Kirin
9.5.1 Kyowa Hakko Kirin: Allergic Rhinitis Drugs Portfolio, 2015
9.5.2 Kyowa Hakko Kirin: Sales Forecast 2015-2025
9.6 Merck & Co.
9.6.1 Merck: Allergic Rhinitis Drugs Portfolio, 2015
9.6.2 Merck: Recent Developments
9.6.2.1 Bayer Acquires Merck’s Consumer Health Business
9.6.2.2 FDA Rejects Singulair OTC Switch
9.6.3 Merck: Sales Forecast 2015-2025
9.6.4 Merck: Allergic Rhinitis Drug Development Pipeline, 2015
9.7 Sanofi
9.7.1 Sanofi: Allergic Rhinitis Drugs Portfolio, 2015
9.7.2 Sanofi: Sales Forecast 2015-2025
9.8 Stallergenes
9.8.1 Stallergenes: Allergic Rhinitis Drugs portfolio, 2015
9.8.2 Stallergenes: Recent Developments
9.8.2.1 Stallergenes Acquires Argentinean Company Alergo Pharma
9.8.2.2 Greer Launches Oralair In The US
9.8.2.3 Proposed Merger With Greer
9.8.3 Stallergenes: Sales Forecast 2015-2025
9.8.4 Stallergenes: Allergic Rhinitis Drug Development Pipeline, 2015
9.9 UCB
9.9.1 UCB: Allergic Rhinitis Drugs Portfolio, 2015
9.9.2 UCB: Sales Forecast 2015-2025
9.10 Other Leading Companies Within The Allergic Rhinitis Drugs Market
10. Allergic Rhinitis Drugs: Research And Development Pipeline, 2015-2025
10.1 Trends And Developments In The Allergic Rhinitis Pipeline
10.2 The R&D Pipeline For Oral Antihistamine, 2015
10.2.1 Talion (bepotastine) – Mitsubishi Tanabe
10.2.2 ZPL-3893787 (histamine H4R antagonist) – Ziarco Pharma
10.2.3 ZPL-868087 (oral histamine H3R antagonist) – Ziarco Pharma
10.3 The R&D Pipeline For Intranasal Corticosteroids, 2015
10.3.1 APC-3000 (HFA inhaled corticosteroid) – Adamis Pharmaceuticals
10.3.2 S0597 (topical glucocorticoid) – Sun Pharmaceuticals
10.3.3 TBS-6 – Trimel Pharmaceuticals
10.4 The R&D Pipeline For Immunotherapy In Allergic Rhinitis, 2015
10.4.1 Actair (house dust mite SLIT; STG320) – Stallergenes/Shionogi & Co
10.4.2 AllerT (subcutaneous birch pollen immunotherapy) – Anergis
10.4.3 Cat-SPIRE and other -SPIRE Therapies (synthetic peptide immunoregulatory epitopes) – Circassia Pharmaceuticals
10.4.4 Depigoid Birch 5000 (birch pollen allergen extract, Leti Pharma
10.4.5 House Dust Mite SLIT-Tablet (MK-8237) – ALK-Abelló/Merck/Torii
10.4.6 Pollinex Quattro (subcutaneous immunotherapies) – Allergy Therapeutics
10.4.7 gp-ASIT+ (grass pollen allergen fragments) – Biotech Tools
10.4.8 Betula verrucosa (Bet v) 1 allergen – Stallergenes
10.5 The R&D Pipeline for Other Allergic Rhinitis Drugs
10.5.1 eN-Lac (Lactobacillus paracasei GMNL-32) – GenMont Biotech
10.5.2 S-555739 (prostaglandin D2 receptor antagonist) – Shionogi
10.5.3 DSP-3025/AZD-8848 (toll-like receptor 7 agonist) – Dainippon Sumitomo/ AstraZeneca
10.5.4 GSK2245035 (toll-like receptor 7 agonist) – GSK
10.5.5 HP-3060 (transdermal long-acting tape) – Hisamitsu
10.5.6 MRX-4 (anti-inflammatory agent) – Celsus Therapeutics
10.5.7 OC459 (OC000459) – Oxagen/ Atopix Therapeutics /Eleventa
10.5.8 ONO-4053 (prostaglandin D2 receptor antagonist) – Ono Pharmaceutical
10.5.9 WF10 (tetrachlorodecaoxygen chlorite matrix) – Nuvo Research
10.5.10 RPL554 (PDE-3/PDE-4 antagonist) – Verona Pharma
10.5.11 VTX-1463 (toll-like receptor 8 agonist) – VentiRx
11. Qualitative Analysis Of The Allergic Rhinitis Drugs Market, 2015-2025
11.1 Market Factors Influencing Allergic Rhinitis Drugs
11.2 SWOT Analysis Of The Global Allergic Rhinitis Drugs Market, 2015-2025
11.2.1 Strengths
11.2.1.1 OTC-Switch Facilitating Ease Of Consumer Access
11.2.1.2 The Established Role Of Allergic Rhinitis Drugs In Treatment
11.2.1.3 Allergic Rhinitis And The Rising Unmet Clinical Need
11.2.1.4 Rising Profile of Allergic Rhinitis In Various Regions Driving Healthcare Provision
11.2.2 Weaknesses
11.2.2.1 Intranasal Corticosteroids And Patients’ Satisfaction Rates
11.2.2.2 Increasing Penetration Of Generic Drug Products
11.2.2.3 The Challenge Raised By The Low Volume Of Pipeline Developments
11.2.3 Opportunities
11.2.3.1 Growth In Emerging Markets Outstripping Established Markets
11.2.3.2 Rx-to-OTC Switching And The Effects On Revenue Potential
11.2.3.3 Combination Drug Products Providing Rising Efficacy Profiles
11.2.3.4 The Emergence Of Immunotherapy In Allergic Rhinitis
11.2.4 Threats
11.2.4.1 Cost-Containment As A Growth Restraint
11.2.4.2 Rising Cost Of APIs And Manufacturing
11.2.4.3 Patent Expiries And The Resultant Loss Of Revenue
11.3 Porter’s Five Force Analysis Of The Global Allergic Rhinitis Drugs Market, 2015-2025
11.3.1 Power of Buyers
11.3.2 Power Of Suppliers
11.3.3 Threat of Substitutes
11.3.4 Threat Of New Entrants
11.3.5 Rivalry Among Competitors
12. Expert Opinions From Our Primary Research
12.1 Interview with Tonya Winders, President and Chief Executive Officer, Allergy & Asthma Network
12.1.1 Allergy and Asthma Network And The Organisation’s Work In Allergic Rhinitis
12.1.2 Education Efforts Being Implement By Allergy & Asthma Network
12.1.3 Changing Conditions And The Impact On Allergic Rhinitis Prevalence And Severity
12.1.4 Climatic Changes And Its Impact On Allergic Rhinitis Incidence
12.1.5 Immunotherapy – Regulatory Hurdles And Its Adoption
12.1.6 Future Trends – Immunotherapies, Regulatory Approvals, Reimbursement
12.1.7 Allergy & Asthma Network’s Plans For The Future
12.2 Interview with Amena Warner, Nurse Advisor at Allergy UK And President, International Nurses Group In Immunodeficiencies
12.2.1 Allergy UK And The Organisation’s Work In Allergic Rhinitis
12.2.2 Allergy UK’s Patient Education Efforts
12.2.3 The Challenges Associated With The Treatment Options Available To Allergic Rhinitis Patients
12.2.4 Familial And Environmental Factors Influencing Allergic Rhinitis Prevalence
12.2.5 Immunotherapy And Its Impact On The Treatment Landscape For Allergic Rhinitis
12.2.6 Sublingual Immunotherapies And The Expanding Repertoire Of Allergic Rhinitis Treatments
12.2.7 Allergy UK’s Future Plans In Patient Education And Treatment Access
12.3 Interview with Dr Apelles Econs MRCS LRCP, Consultant – Allergy & Nutrition, Allergy Medical UK
12.3.1 On The Aetiology And Progression Of Allergy And Allergic Conditions
12.3.2 Factors Driving Allergic Rhinitis And The Familial Link
12.3.3 Developments And New Technologies In Diagnosing Allergies
12.3.4 Future Trends In Allergic Rhinitis Treatment And Allergy Medical UK’s Plans For The Future
13. Conclusions
13.1 Overview Of Current Market Conditions And Market Forecast, 2014-2025
13.2 Leading Sectors In The Allergic Rhinitis Drugs Market In 2014
13.3 Leading Regions In The Allergic Rhinitis Drugs Market In 2014
13.4 Leading Companies In The Allergic Rhinitis Drugs Market, 2014
13.5 What Does The Future Hold For Allergic Rhinitis Drugs?
【レポート販売概要】
■ タイトル：アレルギー性鼻炎治療薬の世界市場予測：抗ヒスタミン剤、コルチコステロイド、免疫療法、ワクチン■ 英文：Allergic Rhinitis Drugs Market Forecast 2015-2025 : Future Prospects for Companies in Antihistamines, Corticosteroids, Immunotherapy & Vaccines
■ 発行日：2015年9月
■ 調査会社：visiongain
■ 商品コード：VGAIN5091105
■ 調査対象地域：グローバル
- 世界の統合手術室用設備市場：手術室用照明、ブーム、手術台などThe Global Markets for Integrated Operating Room Equipment includes OR integration products that are typically packaged with some combination of OR equipment such as booms/service arms, video systems, monitors, image capture devices, surgical lighting and surgical tables. In addition, some integrated ORs can include an imaging system such as a C-arm, which allows for intra-operative imaging, or a …
- アンモニア、無水・水溶液市場：日本This report is a comprehensive research of ammonia, anhydrous and in aqueous solution market in Japan. The report starts with giving brief country profile for Japan, including general information and main economic indicators. Further, the report provides in-depth analyses ammonia, anhydrous and in aqueous solution market in the country. It identifies key market players, including major producers, …
- Pengrowth Energy Corporation：石油・ガスの開発・生産動向及びコスト分析– Q4, 2012Pengrowth Energy Corporation Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2012 Summary Pengrowth Energy Corporation Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an es …
- デジタル資産管理（DAM）サービスの世界市場：ウェブコンテンツ管理、デジタルコンテンツ管理About Digital Asset Management Digital asset management is a business process that organizes, stores, and retrieves rich media content, apart from managing digital rights and permissions. Rich media assets include music, videos, photos, animations, podcasts, and other multimedia content. It consists of management tasks and decisions surrounding the ingestion, cataloging, storage, retrieval, and di …
- ポリマー発泡体の世界市場2017-2021About Polymer Foam Polymer foams can be manufactured in various ways such as slab stock, extrusion, and various forms of molding. Polymer foams are broadly classified as thermosets and thermoplastics, which are further segmented into flexible and rigid foams. Thermoplastics can be broken down and recycled, whereas thermosets are hard to recycle owing to their heavily crosslinked structure. Technav …
- 神経修復・神経再生の世界市場：生体材料、神経管、神経プロテクター、神経ラップ、デバイスThe global nerve repair and regeneration market is expected to reach USD 10,398.79 million by 2020 from USD 5,945.69 million in 2015 at a CAGR of 11.83%. Nerve injuries are most common in the upper (hand and arm) and lower (leg) extremities. Nerve damages can be caused by either blunt trauma, such as an impact from a fall or from traction injuries from motor vehicle accidents, or sharp trauma, suc …
- 艦艇MRO（整備・修理・分解点検）の世界市場2016-2020About Naval Vessels MRO Naval vessels are differentiated from civilian ships by their design and purpose. Such ships are damage resilient and armed. Naval vessels MRO is crucial for sustaining and extending the life of a vessel. It comprises maintenance, overhauls, routine checks, inspections, repairs, and modifications carried out on a vessel and their components. MRO services assure the safety a …
- ETCシステムの世界市場：ETC車載器、ETC車両検知器About Electronic Toll Collection Systems An electronic toll collection (ETC) system is a sophisticated application that includes a group of technologies to provide automated non-stop cashless payment of road toll at toll plazas or toll collection center. The system works with various technology-enabled products such as transponders, antennas, sensors, and wireless communication devices equipped wi …
- 米国のカリキュラム及びデータ管理市場2016-2020About the Curriculum and Data Management Market in the US Technology driven education system comprises of information, resources, and professional development opportunities and these enable schools to impart education in a digitally rich environment. Primary objective of including technology in education, is to transform traditional teaching methodologies thus enhancing learning and improving the …
- 世界の電気制御・配電機器市場（～2019）：主要10か国This industry report package offers the most up-to-date market data on the actual market situation, trends, and future outlook for electricity control and distribution equipment in the world and in the top 10 global countries. Along with a global electricity control and distribution equipment market report the package includes country reports from the following countries: China, France, Germany, I …
- 世界の酵母（イースト）市場動向及び予測（～2018）The yeast market is flourishing due to the increasing application of yeast and specialty yeast products in the food & beverage industry. The leading companies of yeast market are continuously investing in R&D to develop new products and are using yeast as a new source of food ingredients and additives such as flavors, colors, antioxidants, and vitamins. The usage of yeast in bakery was the highest …
- ロボット燃料補給システムの世界市場予測（～2030年）“Robotic refueling system market projected to grow at CAGR of 50.0% during forecast period” The robotic refueling system market is expected to grow from USD 25 million in 2019 to USD 2.2 billion by 2030, at a CAGR of 50.0% during forecast period. The growing requirement for low-cost mining operations and the need for improved security and safety, while fuel dispensation are the key factors driving …
- 世界の輸送安全及び輸送セキュリティ市場（2014-2018）About Transportation Safety and Transportation Security Transportation safety and security systems are highly advanced systems, which are gaining popularity in recent times. Adequate safety and security remain a prerequisite for any transport system. These systems form part of aviation, cargo supply chain, maritime, and other popular passenger transport systems such as roadways and railways. Law e …
- 世界の指向性エネルギー兵器（DEW）市場（2014-2018）About Directed Energy Weapons Weapons that emit high energy and damage a target with minimum collateral damage are called directed energy weapons. This energy can have different categories such as electromagnetic waves (masers, lasers, radio frequency, and microwave), sound in supersonic form, and particles with mass. TechNavio's analysts forecast the Global Directed Energy Weapons market to grow …
- 太陽光発電とカーボンナノチューブCarbon nanotubes are allotropes of carbon with a cylindrical nanostructure. Nanotubes have been constructed with length-to-diameter ratio of up to 132,000,000:1, which is significantly larger than any other material. These cylindrical carbon molecules have novel properties that make them potentially useful in many applications in nanotechnology, electronics, optics and other fields of materials sc …
